Gainers
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
Companies Reporting Before The Bell
• CNFinance Holdings (NYSE:CNF) is likely to report quarterly loss at $0.01 per share on revenue of $71.18 million.
Bloomberg reports that satellite semiconductor provider SatixFy Communications Ltd agreed to go public via a special purpose acquisition company (SPAC) merger. SatixFy’s…